Contact Us
Phase-Xs | Biologics & Biosimilars | Coherent Market Insights
  • Choose License Type

U.S. Elastomeric Infusion Pumps Market, by Product Type (Variable Rate Elastomeric Pumps and Continuous Rate Elastomeric Pumps), By Indication ( Oncology, Post-operative Care, General Medicine, and Others), By End User ( Ambulatory Surgical Centers, Clinics, Home Care Settings ( Oncology, Post-operative Care, General Medicine & Others ), Hospitals and Others), is estimated to be valued at US$ 258.3 million in 2021 and is expected to exhibit a CAGR of 5.7 % during the forecast period (2022-2028), as highlighted in a new report published by Coherent Market Insights.

Key players operating in the market are focusing on the development of technologically advanced infusion pumps.

For instance, in May 2018, Nipro Corporation, a medical equipment company, launched New SUREFUSER + PCA SET. This device is used for the continuous infusion of an anesthetic which is controlled by a patient according to the level of pain. It is easy to grab and fit in a palm, with a larger button as the switch for injection of drug solution.

U.S. Elastomeric Infusion Pumps Market - Impact of Coronavirus (Covid-19) Pandemic

The coronavirus (COVID-19) outbreak that started from Wuhan, China has spread across continents, affecting various industries globally. The U.S. was amongst the most affected countries during the early stage of the COVID-19 pandemic. Till date the country has a cumulative count of around 31,742,914 cases since the start of the pandemic.

The increasing number of COVID-19 patients has brought a shift in the healthcare infrastructure. Hospitals & clinics are focusing on delivering medication through infusion pumps, for precise administration of specific amounts of medication. In addition, the healthcare organizations are issuing new guidelines for promoting the use of infusion pumps. 

For instance, in May 2020, the U.S. FDA has issued authorization for the use of infusion pumps and associated accessories for treating Covid-19 patients. In addition, the U.S. FDA instructed manufacturing companies to provide instructions and guidelines for cleaning the reusable devices for encouraging their application in home care settings.

Similarly, in April 2020, the U.S. FDA issued policies to expand the remote capabilities and availability of infusion pumps for healthcare professionals during the pandemic. Hence, the COVID-19 pandemic has positive effect on the overall infusion pump market growth.

However, the COVID-19 effect on the elastomeric infusion pump market can be termed moderate. This is owing to the limited studies on the use of elastomeric infusion pumps for treating the coronavirus infected patients hence, the government initiatives are more inclined towards IV infusion pumps and smart pumps. 

Browse 10 Market Data Tables and 19 Figures spread through 106 Pages and in-depth TOC on ‘U.S. Elastomeric Infusion Pumps Market, by Product Type (Variable Rate Elastomeric Pumps and Continuous Rate Elastomeric Pumps), By Indication (Oncology, Post-operative Care, General Medicine, and Others), By End User (Ambulatory Surgical Centers, Clinics, Home Care Settings (Oncology, Post-operative Care, General Medicine, & Others), Hospitals, and Others)

To know the latest trends and insights prevalent in the U.S. elastomeric infusion pumps market, click the link below:

https://www.coherentmarketinsights.com/market-insight/us-elastomeric-infusion-pump-market-4452

Key players operating in the market are focusing on strategic investments in order to increase their manufacturing capacity and product development capacity, which will help them to increase their market presence.

In 2020, Baxter International Inc., a medical device company, invested around US$ 521 Mn on research and development programs to enhance future growth through clinical differentiation. The investment in research and development (R&D), consistent with portfolio optimization, and capital allocation strategies, helps to fuel the company’s future growth and ability to remain competitive in each of the product categories.

Key Takeaways of the U.S. Elastomeric Infusion Pumps Market:

  • The U.S. elastomeric infusion pumps market is expected to exhibit a CAGR of 5.7 % during the forecast period, owing to increasing incidence of chronic diseases such as cancer and advantages of elastomeric pumps
  • Among product type, continuous rate elastomeric pumps segment is estimated to hold major market share in the U.S. elastomeric infusion pumps market during the forecast period, owing to the increasing product offerings of automated and technologically advanced continuous rate elastomeric pumps by major players in the market
  • Among indication, oncology segment is estimated to hold major market share in the U.S. elastomeric infusion pumps market during the forecast period, owing to increasing incidence of cancer in the U.S
  • Among end user type, hospital segment is estimated to hold major market share in the U.S. elastomeric infusion pumps market during the forecast period, owing to increasing hospital spending by cancer patients in the U.S. for treatment of cancers
  • Key players operating in the U.S. elastomeric infusion pumps market include B. Braun Melsungen AG, Baxter International Inc., Werfen, Ambu A/S, Avanos Medical Inc., NIPRO, and Progressive Medical, Inc.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner